share_log

Streamline Health Solns Analyst Ratings

Benzinga Analyst Ratings ·  Nov 21, 2022 09:32
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/21/2022 85.19% Lake Street → $3 Assumes → Buy
05/20/2022 85.19% Lake Street → $3 Initiates Coverage On → Buy

What is the target price for Streamline Health Solns (STRM)?

The latest price target for Streamline Health Solns (NASDAQ: STRM) was reported by Lake Street on November 21, 2022. The analyst firm set a price target for $3.00 expecting STRM to rise to within 12 months (a possible 85.19% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Streamline Health Solns (STRM)?

The latest analyst rating for Streamline Health Solns (NASDAQ: STRM) was provided by Lake Street, and Streamline Health Solns their buy rating.

When is the next analyst rating going to be posted or updated for Streamline Health Solns (STRM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Streamline Health Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Streamline Health Solns was filed on November 21, 2022 so you should expect the next rating to be made available sometime around November 21, 2023.

Is the Analyst Rating Streamline Health Solns (STRM) correct?

While ratings are subjective and will change, the latest Streamline Health Solns (STRM) rating was a with a price target of $0.00 to $3.00. The current price Streamline Health Solns (STRM) is trading at is $1.62, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment